Diabetes 53:1671-1679, 2004
© 2004 by the American Diabetes Association, Inc.
Regulation of Resistin Expression and Circulating Levels in Obesity, Diabetes, and Fasting
Michael W. Rajala1,
Yong Qi2,
Hiral R. Patel2,
Nobuhiko Takahashi2,
Ronadip Banerjee2,
Utpal B. Pajvani1,
Madhur K. Sinha3,
Ronald L. Gingerich3,
Philipp E. Scherer1, and
Rexford S. Ahima2
1 Department of Cell Biology and Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York
2 Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania
3 Linco Research, St. Charles, Missouri
Resistin was originally reported as an adipose tissue–specific hormone that provided a link between obesity and diabetes. Resistin protein level was elevated in obese mice and decreased by insulin-sensitizing thiazolidinediones. Immunoneutralization of resistin improved insulin sensitivity in diet-induced obese mice, while the administration of exogenous resistin induced insulin resistance. More recently, we have shown that ablation of the resistin gene in mice decreased fasting glucose through impairment of gluconeogenesis, while resistin treatment in these knockout mice increased hepatic glucose production. However, the link between resistin and glucose homeostasis has been questioned by studies demonstrating reduced, rather than increased, resistin mRNA expression in obese and diabetic mice. To better understand the regulation of resistin, we developed a sensitive and specific RIA resistin that could accurately measure serum resistin levels in several mouse models. We show that while resistin mRNA is indeed suppressed in obese mice, the circulating resistin level is significantly elevated and positively correlated with insulin, glucose, and lipids. Both resistin mRNA expression and protein levels in Lepob/ob mice are suppressed by leptin treatment in parallel with reductions in glucose and insulin. In wild-type mice, serum resistin increases after nocturnal feeding, concordant with rising levels of insulin. Resistin mRNA and protein levels decline in parallel with glucose and insulin during fasting and are restored after refeeding. We performed clamp studies to determine whether resistin is causally related to insulin and glucose. Adipose resistin expression and serum resistin increased in response to hyperinsulinemia and further in response to hyperglycemia. Taken together, these findings suggest that the nutritional regulation of resistin and changes in resistin gene expression and circulating levels in obesity are mediated, at least in part, through insulin and glucose.
Address correspondence and reprint requests to Rexford S. Ahima, MD, PhD, University of Pennsylvania School of Medicine, Division of Endocrinology, Diabetes and Metabolism, 764 Clinical Research Building, 415 Curie Blvd., Philadelphia, PA 19104. E-mail: ahima{at}mail.med.upenn.edu
Abbreviations:
DEXA, dual-energy X-ray absorptiometry; ELISA, enzyme-linked immunosorbent assay; RIA, radioimmunoassay; TBS, Tris-buffered saline; TZD, thiazolidinedione

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Li, C. Jiang, G. Xu, N. Wang, Y. Zhu, C. Tang, and X. Wang
Homocysteine Upregulates Resistin Production From Adipocytes In Vivo and In Vitro
Diabetes,
April 1, 2008;
57(4):
817 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-W. Wang, H.-F. Hung, H. Chang, P. Kuan, and K.-G. Shyu
Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-{alpha}
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2305 - H2312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine,
June 1, 2007;
232(6):
727 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fantuzzi and T. Mazzone
Adipose Tissue and Atherosclerosis: Exploring the Connection
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
996 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Clerc, M. G. Coll Constans, H. Lulka, S. Broussaud, C. Guigne, S. Leung-Theung-Long, C. Perrin, C. Knauf, C. Carpene, L. Penicaud, et al.
Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice
Endocrinology,
March 1, 2007;
148(3):
1039 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lambin, R. van Bree,, I. Vergote, and J. Verhaeghe
Chronic Tumor Necrosis Factor-{alpha} Infusion in Gravid C57BL6/J Mice Accelerates Adipose Tissue Development in Female Offspring
Reproductive Sciences,
December 1, 2006;
13(8):
558 - 565.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Trujillo and P. E. Scherer
Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev.,
December 1, 2006;
27(7):
762 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Ahima, Y. Qi, N. S. Singhal, M. B. Jackson, and P. E. Scherer
Brain Adipocytokine Action and Metabolic Regulation
Diabetes,
December 1, 2006;
55(Supplement_2):
S145 - S154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Qi, Z. Nie, Y.-S. Lee, N. S. Singhal, P. E. Scherer, M. A. Lazar, and R. S. Ahima
Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency
Diabetes,
November 1, 2006;
55(11):
3083 - 3090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Poirier, J. S. Shapiro, R. J. Kim, and M. A. Lazar
Nutritional Supplementation With trans-10, cis-12-Conjugated Linoleic Acid Induces Inflammation of White Adipose Tissue
Diabetes,
June 1, 2006;
55(6):
1634 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Hertzel, L. A. Smith, A. H. Berg, G. W. Cline, G. I. Shulman, P. E. Scherer, and D. A. Bernlohr
Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E814 - E823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-D. Nusken, J. Kratzsch, V. Wienholz, W. Stohr, W. Rascher, and J. Dotsch
Circulating resistin concentrations in children depend on renal function
Nephrol. Dial. Transplant.,
January 1, 2006;
21(1):
107 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Mitchell, D T Armstrong, R L Robker, and R J Norman
Adipokines: implications for female fertility and obesity
Reproduction,
November 1, 2005;
130(5):
583 - 597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W.K. Ng, G. F. Watts, M. S. Farvid, D. C. Chan, and P. H. R. Barrett
Adipocytokines and VLDL Metabolism: Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?
Diabetes,
March 1, 2005;
54(3):
795 - 802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Reilly, M. Lehrke, M. L. Wolfe, A. Rohatgi, M. A. Lazar, and D. J. Rader
Resistin Is an Inflammatory Marker of Atherosclerosis in Humans
Circulation,
February 22, 2005;
111(7):
932 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Steppan, J. Wang, E. L. Whiteman, M. J. Birnbaum, and M. A. Lazar
Activation of SOCS-3 by Resistin
Mol. Cell. Biol.,
February 15, 2005;
25(4):
1569 - 1575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Lazar
How Obesity Causes Diabetes: Not a Tall Tale
Science,
January 21, 2005;
307(5708):
373 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sato, K. Kobayashi, T. Inoguchi, N. Sonoda, M. Imamura, N. Sekiguchi, N. Nakashima, and H. Nawata
Adenovirus-Mediated High Expression of Resistin Causes Dyslipidemia in Mice
Endocrinology,
January 1, 2005;
146(1):
273 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|